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dherence is very important issue in any drug therapy especially in psychiatric illnesses. 
Medicines do not work if not taken and if taken in accordance with advice, provide maximum 
benefit in terms of positive clinical outcomes. Adherence is defined as the extent to which a 
patient's behavior coincides with medical or prescribed health advice. The term adherence is 
preferred over compliance. Non-adherence is a major risk factor for unfavorable clinical outcomes in 
psychiatry patients. Observational study was carried out at Nishtar Hospital, Multan; locate in Southern 
Punjab (Pakistan). A questionnaire was designed for this study “Adherence to drug therapy”. Results 
had shown that relapses occur because of non-adherence. Major reasons for non- adherence include 
inappropriate information given to patient (30%), worries about addiction to medicines (20%), 
worries about continuous long term use (10%) and others (40%), poor financial resources and 
non-availability of pharmacist etc. In conclusion adherence to medication regimen among patients 
with psychiatric disorders is poor. These findings suggest the need for new approaches for increasing 
patient compliance. 
Keywords: Psychiatric illness, Non-adherence, Disability. 
1. INTRODUCTION 
Adherence is better-suited term for psychiatric 
patient because it shifts responsibility of drug 
therapy on health care provider. Adherence is 
defined as the extent to which a patient's 
behaviour coincides with medical or prescribed 
health advice. Adherence is considered 
non-judgmental and is preferred over the term 
"compliance," which carries negative 
connotations and suggests blame for the patient 
(Juliu et al., 2009). Compliance usually means 
"the extent to which the patient takes the 
medications as prescribed." Instead of 
"compliance," it has been suggested that the 
term adherence be used, which puts more of a 
burden on the clinician to form a therapeutic 
alliance with the patient, which thereby 
increases behavioral compliance and possibly 
enhances the therapeutic effect of the 
medication administered (Fawcett, 1995). 
Another term “concordance” is also used which 
is defined as the degree to which clinical advice 
and health behaviour agrees (Alex Jmitchell and 
Thomas Selmes, 2007). Medication 
non-adherence can be intentional or 
unintentional. Some underlying factors for 
unintentional non-adherence include complex 
medication regimes, an inability to pay for 
medications, forgetfulness, and/or failure to 
understand instructions due to auditory, visual, 
psychological, or intellectual impairments, 70% 
of non-adherence cases are intentional (Lehne 
et al., 1994) 
A number of interventions can promote and 
ensure adherence among patients with a 
psychiatric illness. These include: Insuring that 
the medication is actually swallowed and not 
"cheeked" or vomited, encouraging family 
members to oversee medication administration, 
providing patients with written and verbal 
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instructions on dosage and timing, informing 
patients and families that psychotropic 
medications need to be taken on a regular 
schedule to be effective, informing patients 
about side effects of treatment and teaching 
them how to minimize undesired responses, 
assuring patients that psychotropic medications, 
such as antidepressants, antipsychotics, and 
mood stabilizers do not cause addiction,    
establishing a therapeutic relationship with the 
patient and with family and/or significant 
others who are sources of support to the patient 
(Lehne et al., 1994; Napholz, 1997). 
To elucidate predictors of non-adherence among 
psychiatric patients presenting at a tertiary care 
hospital of Pakistan. Factors associated with 
non-adherence among psychiatric patients 
showed that out of 128 patients, those with 
co-morbidity (32.81%) were less adherent than 
those without co-morbidity (p -value: 0.002). 
Adherence among depressed was 61.53%; 
psychotic was 58.82%; bipolar disorder was 
73.91%. Reasons for non-adherence included 
sedation (30%), medication cost (22%), forgot 
to take medication (36%); and inability of the 
physicians to explain timing and dose (92%) or 
benefit of medication (76%) (Taj et al., 2008) 
The patient’s social functioning, acceptance of 
dose, compliance or lack of compliance, and the 
relative benefits of medication are factors that 
contribute to treatment goals (Diamond, 1985). 
The issue of medication compliance is a 
multidimensional phenomenon that rests not 
only with the patient, but also with the 
interactions of caregivers. Study results revealed 
that nurses and patients generally perceive 
estimated frequency of medication compliance 
to be similar (Lund and Frank, 1991). 
Compliance with antidepressant medication is 
important in order to achieve all the goals of 
antidepressant therapy. These goals include 
symptom resolution, restoration of normal 
functioning and prevention of relapse or 
recurrent episodes (Demyttenaere and Haddad, 
2000). Poor adherence with prescribed therapy 
often results in decreased efficacy, annoying for 
patient both and physician. Negative health 
improvement adds extensive costs to the 
healthcare system (Kohler and Maibach, 2001). 
Scientifically, compliance can be expressed as 
the ratio between observed treatment behaviour 
and given treatment standards (Fleischhacker et 
al., 2003). 
The basic objective of the study was to 
determine compliance level of the psychiatric 
patients, causes, severity of non-compliance, 
major factors contributing to noncompliance, 
how physician-patient, nurse-patient, 
attendant-patient relationship effect compliance 
and to develop basic strategies to determine how 
pharmaceutical care approach can established 
to improve compliance in these psychiatric 
patient.  
2. METHODS 
Recruitment to study started in June 2012 
within a time period of three month at Nishtar 
Hospital Multan (Pakistan). Patients were 
selected randomly from indoor and outdoor 
department of hospital. It was an observational 
study and patients involved in it were mostly 
adult and geriatric.  Data collected with help of 
questionnaire. Data analysis was performed 
using SPSS version 16.0. Cross tabulation was 
used in the form of frequencies and Chi-square 
test was used. Generally the comparison was 
made at 5% level of significance. 
3. RESULTS 
3.1 Phytochemical screening 
Patient with psychiatric disorder at Nishtar 
Hospital Multan were mostly with continuous 
course of illness. Major reasons for 
non-adherence were due to only (26%) patients 
were fully agreed to take their medication, (38%) 
were partially agreed, (22%) were not agreed 
and (14%) showed resistance while taking 
medicine (Figure 1). Only (20%) patients were 
cooperative as well as communicative, (44%) 
non-cooperative but communicative, patients 
were communicate but not willing to cooperate 
(18%), patient who neither communicate nor 
cooperate (14%), While (4%) patients were 
mute (Figure 2). 
Reasons contributing to the failure of 
medication plan included cognitive 
disorientation (14%), failure by physician to 
explain (30%), and addiction to medication 
(20%), continuous long term use (10 %) and 
other reasons (26 %) as shown in (Table  3). 
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Figure 2: Behavior of patient contributing to non-compliance 
 
 
Table1: Risks of relapses in psychiatric patients 
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Table 2: Association between reasons for discontinuation of treatment and patient’s vulnerability to 
different conditions 
Pearson Chi-Square = 26.49      P-Value = 0.089 
Where, A = no longer feel ill, B = dislike the idea of indefinite intake, C = not waiting theirs mood to be 
controlled by medicine, D = In hope of improving mood by stooping medication.  
The Value of chi-Square indicates insignificant results, so both Non-complaint patient vulnerable to 
homelessness, housing instability etc. and reasons of discontinuation of treatments are independent at 
5% level of significance. 
Table 3: Reasons of not following up medication plans 
Reasons of not following up 
medication plans 
 Percent 
Cognitive disorientation     14    
Failure by physician to explain    30    
Addiction to medication     20    
Continuous long term use 
Others   
   10 
26 
   
 
4. DISCUSSION 
Our study sample was predominantly from 
Nishtar Hospital Multan. Non-compliance was a 
major risk factor in patients with psychiatric 
disorder. Majority of patient were non-compliant 
and because of discontinuation of treatment 
(20%) patients were admitted to hospital due to 
relapse. Approximately (44%) patients were 
non- cooperative although they were 
communicative. 
 
Even medicines were used to improve their 
quality of life but only (26%) patients were fully 
agreed to take medication, (38%) partially 
agreed and (22%) were not agreed. The result 
indicated that patients were reluctant to adhere 
the medication plan because (22%) patients 
complained that medicines were of bad taste. 
and (44%) large number of doses and (8%) 
patient perception. Because of such attitude 
(52%) patients were partially compliant and 
(24%) showed non-compliance. In NMC 
substance abuse was a major issue in 
compliance (12%) patient were involve in 
Noncompliant  
patient  
vulnerable to                    Reasons for discontinuation of treatment cross tabulation 
  A B C D Total 
Homelessness 0 1 2 0 3 
Housing instability 3 4 6 2 15 
Victimization 1 3 1 0 5 
Poor nutrition 0 0 1 0 1 
Inadequate financial resources 
 
9 10 3 1 23 
All 0 0 1 1 2 
Other 0 0 0 1 1 
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substance abuse. Physician also contributed to 
non-adherence about (30%) physician failed to 
explain properly about positive aspect of 
treatment that was a major contributing factor 
to non-adherence. As Pakistan is an under 
developed countries, so most of patients 
admitted in Nishtar Hospital, Multan (23%). So it 
becomes difficult to say that adherence was only 
limited to patients follow up medication but it 
involves many factors. Non-adherence put an 
extra financial burden on patient as well as on 
health care system in terms of wasted 
resources. 
5. RECOMMENDATIONS 
As psychiatric illnesses are long lasting so 
computer based data collection system should 
present to avoid loss of data and hence relapse. 
2) Under Pakistani scenario join family systems 
are very strong so provide information about 
drug therapy to patient’s attendants 
3) To reduce predisposing factors like wrong 
belief, knowledge and perception about the 
disease conduct seminars and other reinforcing 
activities. 
4) To provide better pharmaceutical care 
presence of pharmacist is important and in 
Nishtar Hospital Multan number of pharmacist 
are disproportional and are not in accordance 
with government policy so number of 
pharmacist should be increased to improve 
patient quality of life and to provide best drug 
therapy.  
5) The on hospital faculty with collaboration of 
government must make such policies in which 
rehabilitative activates should be performed 
industrial scale. 
6) To avoid relapses in patient’s physician must 
explain about duration of treatment and patients 
must not discontinue their treatment of their 
own. 
7) Supports are important health activity, 
although supports room was present but these 
should be performed) at national level. 
8) There should be a strong physician-patient 
relationship to improve adherence. 
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